AFT Pharmaceuticals Limited (NZE: AFT)

AFT Pharmaceuticals Income Statement

Financials in millions NZD. Fiscal year is April - March.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Revenue	195.41	195.41	156.64	130.31	113.11	105.6
Revenue Growth (YoY)	24.75%	24.75%	20.20%	15.22%	7.11%	24.05%
Cost of Revenue	107.14	107.14	83.66	68.54	64.36	57.33
Gross Profit	88.27	88.27	72.98	61.78	48.74	48.27
Selling, General & Admin	58.09	58.09	49.4	37.99	36.69	37.3
Research & Development	6.47	6.47	3.91	3.62	1.97	-
Other Operating Expenses	-0.53	-0.53	-	-0.23	-0.63	-0.54
Operating Expenses	64.04	64.04	53.31	41.39	38.03	36.76
Operating Income	24.24	24.24	19.67	20.39	10.71	11.5
Interest Expense	-3.69	-3.69	-2.87	-2.44	-3.44	-6.96
Interest & Investment Income	0.07	0.07	0.01	0	0	0.02
Earnings From Equity Investments	-	-	-	-	-	-0.08
Currency Exchange Gain (Loss)	1.11	1.11	-3.14	0.64	0.24	-2.13
Other Non Operating Income (Expenses)	0.3	0.3	2.13	0.09	0.38	0.73
EBT Excluding Unusual Items	22.02	22.02	15.8	18.69	7.89	3.09
Gain (Loss) on Sale of Investments	-	-	-	-	-	9.78
Pretax Income	22.02	22.02	15.8	18.69	7.89	12.88
Income Tax Expense	6.41	6.41	5.15	-1.16	0.11	0.19
Net Income	15.61	15.61	10.65	19.85	7.78	12.69
Preferred Dividends & Other Adjustments	-	-	-	-	0.19	0.99
Net Income to Common	15.61	15.61	10.65	19.85	7.59	11.7
Net Income Growth	46.51%	46.51%	-46.32%	155.05%	-38.69%	-
Shares Outstanding (Basic)	105	105	105	105	103	97
Shares Outstanding (Diluted)	105	105	105	105	103	97
Shares Change (YoY)	0.02%	0.02%	0.16%	1.34%	6.15%	0.00%
EPS (Basic)	0.15	0.15	0.10	0.19	0.07	0.12
EPS (Diluted)	0.15	0.15	0.10	0.19	0.07	0.12
EPS Growth	46.48%	46.48%	-46.41%	168.07%	-39.61%	-
Free Cash Flow	28.75	28.75	11.43	13.82	0.66	14.79
Free Cash Flow Per Share	0.27	0.27	0.11	0.13	0.01	0.15
Dividend Per Share	0.016	0.016	0.011	-	-	-
Dividend Growth	45.45%	45.45%	-	-	-	-
Gross Margin	45.17%	45.17%	46.59%	47.40%	43.09%	45.71%
Operating Margin	12.40%	12.40%	12.56%	15.65%	9.47%	10.89%
Profit Margin	7.99%	7.99%	6.80%	15.23%	6.71%	11.08%
Free Cash Flow Margin	14.71%	14.71%	7.30%	10.61%	0.58%	14.00%
EBITDA	24.63	24.63	19.88	20.67	10.97	11.77
EBITDA Margin	12.61%	12.61%	12.69%	15.86%	9.70%	11.14%
D&A For EBITDA	0.4	0.4	0.21	0.28	0.26	0.26
EBIT	24.24	24.24	19.67	20.39	10.71	11.5
EBIT Margin	12.40%	12.40%	12.56%	15.65%	9.47%	10.89%
Effective Tax Rate	29.11%	29.11%	32.57%	-	1.33%	1.44%

Source: S&P Capital IQ. Standard template. Financial Sources.